RAI Tatemitsu

J-GLOBAL         Last updated: Jan 17, 2020 at 02:59
 
Avatar
Name
RAI Tatemitsu
Affiliation
Tokyo Medical and Dental University
Section
Graduate School of Medical and Dental Sciences Endowed Departments Department of Nephrology and Regional Health(ibaraki)
Job title
Professor
Other affiliation
Tokyo Medical and Dental UniversityTokyo Medical and Dental UniversityTokyo Medical and Dental University
Research funding number
80334431

Research Areas

 
 

Academic & Professional Experience

 
Jan 1900
 - 
Today
Associate Professor, Graduate School of Medical and Dental Sciences Medical and Dental Sciences Systemic Organ Regulation Nephrology, Tokyo Medical and Dental University
 
Apr 2016
 - 
Today
Graduate School of Medical and Dental Sciences Medical and Dental Sciences Systemic Organ Regulation Nephrology, Tokyo Medical and Dental University
 
Nov 2015
 - 
Today
Professor, Graduate School of Medical and Dental Sciences Endowed Departments Department of Nephrology and Regional Health(ibaraki), Tokyo Medical and Dental University
 
Apr 2001
 - 
Today
Professor, Graduate School of Medical and Dental Sciences Endowed Departments Department of Nephrology and Regional Health(ibaraki), Tokyo Medical and Dental University
 

Published Papers

 
Yoshiaki Matsuura, Naohiro Nomura, Wakana Shoda, Takayasu Mori, Kiyoshi Isobe, Koichiro Susa, Fumiaki Ando, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida
Biochem. Biophys. Res. Commun.   517(2) 364-368   Sep 2019
mice, and that calcineurin inhibitors might be effective for treating type 4 BS.
Tamami Fujiki, Fumiaki Ando, Kana Murakami, Kiyoshi Isobe, Takayasu Mori, Koichiro Susa, Naohiro Nomura, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida
Sci Rep   9(1) 9245-9245   Jun 2019
Tolvaptan, a vasopressin type 2 receptor antagonist initially developed to increase free-water diuresis, has been approved for the treatment of autosomal dominant polycystic kidney disease in multiple countries. Furthermore, tolvaptan has been sho...
Atsushi Ohkubo, Tomokazu Okado, Takatoshi Sakurasawa, Takuma Maeda, Ayako Itagaki, Hiroko Yamamoto, Satoko Miyamoto, Hiroshi Seshima, Naoki Kurashima, Takayasu Mori, Soichiro Iimori, Eisei Sohara, Tatemitsu Rai, Shinichi Uchida, Shotaro Naito
Ther Apher Dial   23(3) 271-278   Jun 2019
Autoimmune neurological diseases are often treated by immunoadsorption using a conventional plasma separator and tryptophan-immobilized column (IA). However, there is only one case report on treatment with immunoadsorption using a selective plasma...
Soichiro Suzuki, Shotaro Naito, Yoshiyuki Numasawa, Mizuho Asada, Norikazu Shoji, Moko Zeniya, Daiei Takahashi, Hidehiko Sato, Soichiro Iimori, Naohiro Nomura, Eisei Sohara, Tomokazu Okado, Yasuyoshi Ishiwata, Masashi Nagata, Tatemitsu Rai, Takanori Yokota, Shinichi Uchida
Intern. Med.   58(12) 1775-1779   Jun 2019
Encephalopathy is a rare side effect of cephalosporin treatment. We herein present a case of encephalopathy induced by ceftriaxone, a third-generation cephalosporin, in a patient with renal failure. An 86-year-old woman on maintenance hemodialysis...
Sayaka Yoshida, Yuya Araki, Takayasu Mori, Emi Sasaki, Yuri Kasagi, Kiyoshi Isobe, Koichiro Susa, Yuichi Inoue, Pascale Bomont, Tomokazu Okado, Tatemitsu Rai, Shinichi Uchida, Eisei Sohara
Clin. Exp. Nephrol.   22(6) 1251-1257   Dec 2018
Pseudohypoaldosteronism type II (PHAII) is a hereditary hypertensive disease caused by mutations in four genes: WNK1, WNK4, Kelch-like3 (KLHL3), and cullin3 (CUL3). Recently, it was revealed that CUL3-KLHL3 E3 ligase complex ubiquitinates WNK1 and...

Conference Activities & Talks

 
Metformin Has Natriuretic Effects Through Reduction of the Sodium-Chloride Cotransporter Phosphorylation.
27 Oct 2018   
Molecular Mechanism of High-Potassium Induced Na-Cl Cotransporter Dephosphorylation.
27 Oct 2018   
Amelioration of Renal Fibrosis and Tubulointerstitial Damage in Fat-1 Transgenic CKD Mice by Compensation of Decreased Omega-3 Fatty Acids in the Kidney
27 Oct 2018   
WNK1 Regulates Skeletal Muscle Hypertrophy by Modulating Phosphorylation, Nuclear Localization, and Transcriptional Activity of FoxO4
27 Oct 2018   
Tolvaptan Activates Nrf2/HO-1 Pathway Through PERK Phosphorylation
27 Oct 2018